New Florida Bill Proposes Decriminalization of Psychedelics (and Every Other Illegal Drug)
A new bill filed in Florida has proposed the decriminalization…
Author: Emily Jarvie
Psychedelic Business Spotlight: November 26
This week in psychedelic business news: Compass Pathways files another patent; Seelos Therapeutics raises big money; Cybin makes psychedelic therapy more accessible in NYC.
PharmaTher Believes Ketamine Could Treat This Rare Neurological Condition
The company is also exploring if ketamine can treat other neurological conditions, including Parkinson’s Disease, ALS, and CRPS.
Manhattan Hospital Partners with Cybin to Provide Psychedelic Therapies to Marginalized Communities
“It’s time for psychedelic medicine to climb down from the ivory tower and into the community,” says Cybin Chief Clinical Officer Dr. Alex Belser.
New Evidence Microdosing Psychedelics Reduces Anxiety and Depression
This study also showed microdosers were less likely to use alcohol and were most likely to abstain from consuming alcohol entirely.
Psychedelic Business Spotlight: November 19
This week in psychedelic business news: Companies partner on new dosage method; MindMed investigates LSD microdosing; Health Canada allows a psilocybin production campus.
Jada Pinkett Smith Tackles Exclusion of People of Color From Psychedelic Research on ‘Red Table Talk’
“We know nothing scientific about psychedelics and people of color and how appropriate our treatments are for people in those communities,” says psychedelic researcher Dr. Monnica Wiliams.
American Overdose Deaths Reach Record High During COVID Pandemic—And New Study Shows Psychedelics Can Help
“After adjusting for a range of potential confounders, psychedelic use remained independently associated with a significantly reduced odds of subsequent daily opioid use,” researchers say.
Australian Doctor Sues State Over Patient Access to MDMA
“People will continue to kill themselves, and my patient will continue to suffer in silence until the Victorian Government allows me to access a new treatment which may finally bring peace to a troubled mind,” says Dr. Eli Kotler.
How does Time of Day Influence LSD Microdosing? New MindMed Study Hopes to Find Out
“Our goal is to provide insight on key parameters that may impact and explain the mechanisms behind low-dose treatments,” says MindMed Executive President Dr. Miri Halperin Wernli.
End of content
End of content